Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Ceevra Reveal 2.0

K-Number: K173274 · 2018-07-10

ApplicantCeevra, Inc.
Decision Date2018-07-10
Product CodeLLZ
Advisory CommitteeRA
DecisionSubstantially Equivalent

Device Summary

Ceevra Reveal 2.0 is a medical device manufactured by Ceevra, Inc.. It received FDA 510(k) clearance on 2018-07-10 under approval number K173274. The device is classified under product code LLZ. It was reviewed by the RA advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Ceevra Reveal 2.0?

Ceevra Reveal 2.0 is a medical device that received FDA 510(k) clearance on 2018-07-10. It is manufactured by Ceevra, Inc.. The 510(k) number is K173274.

When was Ceevra Reveal 2.0 approved by the FDA?

Ceevra Reveal 2.0 received FDA 510(k) clearance on 2018-07-10, under approval number K173274.

What company makes Ceevra Reveal 2.0?

Ceevra Reveal 2.0 is manufactured by Ceevra, Inc..

What is the FDA product code for Ceevra Reveal 2.0?

The FDA product code for Ceevra Reveal 2.0 is LLZ.

Other Devices by Ceevra, Inc.

K171356Clarity Reveal K233568Ceevra Reveal 3+ K222676Ceevra Reveal 3 K243933Ceevra Reveal 3+

Related Devices (Code: LLZ)

K161959ClearView cCADClearview Diagnostics, Inc. K163539Ez3D-i / E3Ewoosoft Co., Ltd. K162955Multi-Modality Tumor Tracking (MMTT) applicationPhilips Medical Systems Nederland B.V. K160852ZiaZetta Medical Technologies, LLC K162376CAAS MR 4D FlowPie Medical Imaging BV K161322CT CoPilotZepmed, LLC

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑